Abstract
The Northwestern China is a typical arid and semi-arid region of inner Asia, where some important medicinal species such as Angelica sinensis, Radix astragali, Radix codonopsis, Radix et rhizoma rhei, Radix glycyrrhizae, Lycium barbarum L are found and grew in the mountains areas, or desert areas. Among them, A. sinensis, R. astragali and R. glycyrrhizae are frequently used in traditional Chinese medicines and herbal prescriptions, thus encouraged many researchers to investigate and develop them. Our purpose is to provide a review of recent advances about three typical medicinal plants of A. sinensis, Astragalus membranaceus and R. glycyrrhizae in Northwestern China, mainly referring to botanical identity, chemical constituents, pharmacological studies, application in formulation, safety and cultivation practices. That will provide some valuable information for the further study and development of medicinal plants in Northwestern China.
Keywords
- medicinal plants
- Northwestern China
- Angelica sinensis
- Radix astragali
- Radix glycyrrhizae
1. Introduction
Approximately 8300 wild plant species of known medicinal species in the Northwestern China, some 400 species are used in traditional Chinese medicines (TCM) or by drug manufacturing units in China. Most of these medicinal plants grow in the arid and semi-arid marginal mountains areas, or desert areas of Northwestern China.
This chapter aims to provide a review of recent advances in the fields of botanical identity, chemical constituents, pharmacological studies, application in formulation, safety and cultivation practices about three typical medicinal plants of
2. Angelica sinensis
当归 (Danggui,
2.1. Botanical identity

Figure 1.
Photographs of
2.2. Chemical constituents
Studies have shown that

Figure 2.
Chemical structures of the major organic acids in
2.3. Pharmacological studies
2.4. Application in formulation
These are ready-made combinations of herbs available to the general public to treat certain conditions without reference to a complete system of medicine. One company alone manufactures 280 of these formulations, designed for specific indications. Of these, 71 contain danggui [10]. Some of the herbs are traditionally put together (“Classic Pairs”), such Danggui and Chuanxiong Rhizoma (Ligusticum chuanxiong) or Danggui and
2.5. Safety
It was reported that no obvious acute toxicity appeared through oral
2.6. Cultivation practices
At present, the market supply of angelica is cultivated varieties. The proper field production altitude is from 2000 to 2500 m above sea level, while the proper seedling field is from 2500 to 2700 m above sea level. The annual average temperature of 4.5–5.7°C and average rainfall of 570–650 mm are suited for cultivating
3. Radix astragali
黄芪 (Huangqi,
3.1. Botanical identity

Figure 3.
Photographs of
3.2. Chemical constituents
To date,

Figure 4.
Chemical structures of the major compounds from Astragalus [
3.3. Pharmacological studies
The Chinese name Huangqi is the symbol of the “yellow leader” in china, linking to the yellow root and its status as one of the most important tonic herbs in traditional Chinese medicine (TCM). It was recorded in “Shen Nong Ben Cao Jing”, the first book of Chinese herbal medicine, and was classified under the group of “qi”-tonifying drugs [28]. Huangqi is one of the 50 fundamental herbs used in TCM and was included in many TCM preparations with a wide range of biological functions [23]. In traditional Chinese medicine,
3.4. Application in formulation
3.5. Safety
Generally,
3.6. Cultivation practices
Seedling transplanting is usually used in the spring, by 20 cm apart in the row, 40 cm spacing between rows and 225,000 plants/ha. Combined with tillage, weeding should be carried out timely during growing period. The main disease in growing periods of
4. Radix glycyrrhizae
甘草 (Gan cao,
4.1. Botanical identity

Figure 5.
Photographs of
In the Northwest of China,
4.2. Chemical constituents

Figure 6.
Structure of glycyrrhizin (I), liquiritin (II), isoliquiritin (III), liquiritigenin (IV) and isoliquiritigenin (V) [
4.3. Pharmacological studies
4.4. Application in formulation
A systematic database was constructed to investigate the frequency of reporting formulations and crude drugs described in Shang-Han-Lun (known as the Treatise on Cold Damage Disorders), a famous prescription in TCM. It consists of 112 kinds of genuine formulations from a total of 430 formulations but due to overlapping or repetition. The best three frequently mentioned prescription were Da-cheng-qi-tang (DCQT), Guizhi-tang (GZT) and Shaoyao-gancao-tang (SYGCT) [46]. Da-cheng-qi-tang, also known as Dai-joki-to in Japanese, is a formulation composed mainly of Rhizoma Rhei and Cortex Magnoliae used for the treatment of interior heat- and excess-syndrome. Clinically, DCQT was widely prescribed to promote the recovery of gastrointestinal motility after abdominal surgery and to treat acute abdominal diseases, such as acute pancreatitis, adhesive bowel obstructions and acute appendicitis [49]. Guizhi-tang contains
4.5. Safety
The acute toxicities of licorice extract containing approximately 53% glycyrrhizin have similar acute toxicity doses and are low in mice and rats. Glycyrrhizin administered 70 mg/kg intravenously has shown acute toxic effects of convulsions and slight hemolysis in mice, whereas toxic effects did not see at lower doses of glycyrrhizin. The majority of short-term toxicity effects on the pituitary-adrenal axis have indicated that glycyrrhizin induced the pseudoaldosteronism at dose and time dependent manner, but the establishment of a clear no observed effect levels (NOEL) is difficult due to the differences in agents tested, animals used and end-points studied. The 90-day NOEL for licorice extract (53% glycyrrhizin) in rats is at the range of 0.31–0.63 g/kg, which delivers approximately glycyrrhizin 165–334 mg/kg [54]. However, for glycyrrhizin, the 30-day NOEL in rats is below 15 mg/kg [55]. In contrast, a two-year disodium glycyrrhizinate administered as high as 229 mg/kg/day or females administered as high as 407 mg/kg/day in mice showed no significant effects on average body weights or mortality, nor any signs of tumorgenicity among male animals. Other studies
4.6. Cultivation practices
A climate condition with an average height of 1000–1500 m above sea level, annual average temperature of 6–8°C and average rainfall of 150–300 mm is suited for cultivating glycyrrhiza. Soil types of chestnut soil, brown soil, sierozem, dark loessial soils, salinized desert meadow soil and a weak alkaline (pH of 8–9) are the most suited for the cultivation of glycyrrhiza. The seedling fields should be chosen in the land of flat terrain, layers deep and fertile soil. Sow the seeds in drills 3–4 cm deep and 20 cm apart. The proper seed sowing time is in the end of April to early of May. Lifting seedling is in the day before transplanting. Transplanting is same as sowing time. Each plot at planting time, spacing of 10–15 cm and 25–30 cm row spacing planting are generally adopt. An under-mulch-drip irrigation or drip irrigation is usually a much better irrigation mode. Combined with tillage, weeding should be carried out timely during growing period. About 45,000 kg/ha of organic manure as base fertilizer with irrigation topdressing PK should be combined depending on soils and plant nutrition. Adopting measure of agricultural and biological prevention and cure control the diseases of rust disease, powdery mildew and brown spot, as well as insects of leaf beetle and
Acknowledgments
This work was supported by the National Natural Science Foundation (81260616, 81660625 and 81603407) and the Natural Science Foundation of Gansu Province (148RJZA061).
References
- 1.
She, M.L., Pu, F.T., Pan, Z.H. Apiaceae. Flora of China Editorial Committee (ED), Flora of China Vol. 14. Missouri Botanical Garden Press, St. Louis, Missouri, 2005. pp. 1–205. (In Chinese) - 2.
Zhao, R.M., Chen, H., Guo, F.X., Wang, Y., Zhang, S.Z., Wang, Q.R. Comparative study on distributed feature of wild Angelica sinensis resources and the different in growth characteristics with its cultivars to Min County of Gansu. Acta Prataculturae Sin.; 2014. 23: 29–37. - 3.
Fang, L., Xiao, X.F., Liu, C.X., He, X. Recent advance in studies on Angelica sinensis . Chin. Herb. Med.; 2012. 4: 12–25. DOI: 10.3969/j.issn.1674-6384.2012.01.004 - 4.
Chen, X.P., Li, W., Xiao, X.F., Zhang, L.L., Liu, C.X. Phytochemical and pharmacological studies on Radix Angelica sinensis . Chin. J. Nat. Med.; 2013. 11: 577–587. DOI: 10.1016/S1875-5364(13)60067-9 - 5.
Jia, Z.S., Guan, T.Y., Cao, G.J. Study on the content of amino acid and micro-element. Amino Acids Biot. Resour.; 1992. 2: 49. (In Chinese) - 6.
Li, G.C., Wei, W.T., Gao, T.J., Li, L.J. Study on the extraction for total flavonoids from Angelica sinensis (Oliv.). Diels and its antibacterial effect. Lishizhen Med. Mater. Med. Res.; 2010. 22: 310–311. (In Chinese) - 7.
Cao, Y., Yan, H., Duan, J.A., Qian, D.W., Song, B.S., Guo, S., Hem, Z.Q. Analysis of nucleosides in the dried roots of Angelica sinensis from different regions. Chin. J. Pharm. Anal.; 2010. 30: 2026–2030. (In Chinese) - 8.
Cao, Z.Y., Fang, J.H., Lu, W., Shen, X. Determination of trace elements for Angelica sinensis by ICP-OES with microwave digestion. Stud. Trace Elem. Health; 2011. 28: 18–20. (In Chinese) - 9.
Zhao, X.J., Wang, H.F., Zhao, D.Q., Ji, H.X., Pei, Y.H., Bai, J. Isolation and identification of the chemical constituents from roots of Angelica sinensis (Oliv. )Diels . J. Shenyang Pharm. Univ.; 2013. 30: 182–185. (In Chinese) - 10.
Wei, W.L., Zeng, R., Gu, C.M., Qu, Y., Huang, L.F. Angelica sinensis in China—A review of botanical profile, ethnopharmacology, phytochemistry and chemical analysis. J. Ethnopharmacol.; 2016. 190: 116–141. DOI: 10.1016/j.jep.2016.05.023 - 11.
Bunel, V., Antoine, M.H., Nortier, J., Duez, P., Stévigny, C. Nephroprotective effects of ferulic acid, Z-ligustilide and E-ligustilideisolated from Angelica sinensis againstcisplatin toxicityin vitro . Toxicol. In Vitro; 2015. 3: 458–467. DOI: 10.1016/j.tiv.2014.12.017 - 12.
Wang, L.Y., Tang, Y.P., Liu, X., Zhu, M., Tao, W.W., Li, W.X., Duan, J.A. Effects of ferulic acid on antioxidant activity in Angelicae Sinensis Radix ,chuanxiong Rhizoma , and their combination. Chin. J. Nat. Med.; 2015. 13: 401–408. DOI: 10.1016/S1875-5364(15)30032-7 - 13.
Hua, Y., Xue, W., Zhang, M., Wei, Y., Ji, P. Metabonomics study on the hepatoprotective effect of polysaccharides from different preparations of Angelica sinensis . J. Ethnopharmacol.; 2014. 151: 1090–1099. DOI: 10.1016/j.jep.2013.12.011 - 14.
Zhao, L., Wang, Y., Shen, H.L., Shen, X.D., Nie, Y., Wang, Y., Han, T., Yin, M., Zhang, Q.Y. Structural characterization and radioprotection of bone marrow hematopoiesis of two novel polysaccharides from the root of Angelica sinensis (Oliv. )Diels . Fitoterapia; 2012. 83: 1712–1720. DOI: 10.1016/j.fitote.2012.09.029 - 15.
Wang, J.M., Ge, B.L., Li, Z.H., Guan, F.X., Li, F.F. Structural analysis and immunoregulation activity comparison of five polysaccharides from Angelica sinensis . Carbohydr. Polym.; 2016. 140: 6–12. DOI: 10.1016/j.carbpol.2015.12.050 - 16.
Saw, C.L., Wu, Q., Su, Z.Y., Wang, H., Yang, Y., Xu, X., Huang, Y., Khor, T.O., Kong, A.N. Effects of natural phytochemicals in Angelica sinensis (Danggui) on Nrf2-mediated gene expression of phase II drug metabolizing enzymes and anti-inflammation. Biopharm. Drug Dispos.; 2013. 34: 303–311. DOI: 10.1002/bdd.1846 - 17.
Wedge, D.E., Klun, J.A., Tabanca, N., Demirci, B.D., Ozek, T., Baser, K.H., Liu, Z., Zhang, S., Cantrell, C.L., Zhang, J. Bioactivity-guided fractionation and GC/MS fingerprinting of Angelica sinensis andAngelica archangelica root components for antifungal and mosquito deterrent activity. J. Agric. Food Chem.; 2009. 57: 464–470. DOI: 10.1021/jf802820d - 18.
Xie, Q.F., Xie, J.H., Dong, T., Su, J.Y., Cai, D.K., Chen, J.P., Liu, L.F., Li, Y.C., Lai, X.P., Tsim, K.W., Su, Z.R. Effect of a derived herbal recipe from an ancient Chinese formula, Danggui Buxue Tang, on ovariectomized rats. J. Ethnopharmacol.; 2012. 144: 567–575. DOI: 10.1016/j.jep.2012.09.041 - 19.
Upton R. American Herbal Pharmacopoeia and Therapeutic Compendium-Dang Gui Root Scotts Valley. CA, USA. 2003. - 20.
Wang, Y.D., Wang, H.Y., Li, L., Zhang, C.G., Zhang, G.X., Zhang, Y., Liu, C.E. Anti-fatigue activity of acanthopanax gracilistylus wine. Chin. J. Health Lab. Technol.; 2009. 19: 1404–1405. (In Chinese) - 21.
Yang, L.X., Dou, W.Y., Yan, C.L., Liu, T.H., Wei, D.W. Study on toxicity of Angelica sinensis i njection andAstragalus membranaceus injection in chorioallantoic membrane model. Chin. J. Exp. Trad. Med. Form.; 2009. 15: 46–48. (In Chinese) - 22.
Yan, L., Wan, T., Zhang, Z., Wang, R.X., Sun, B.W.. Analysis on botanical characters of Astragalus membranaceus Bunge. andA. membranaceus var. mongholicus (Bunge. )Hsiao . J. Inner Mongolia Agric. Univ.; 2001. 22: 71–77. (In Chinese) - 23.
Fu, J., Wang, Z., Huang, L., Zheng, S., Wang, D., Chen, S., Zhang, H., Yang, S. Review of the botanical characteristics, phytochemistry, and pharmacology of Astragalus membranaceus (Huangqi). Phytother. Res.; 2014. 28: 1275–1283. DOI: 10.1002/ptr.5188 - 24.
Tang, W. Eisenbrand, G. Chinese Drugs of Plant Origin. Springer-Verlag, Beijing, 1992. pp. 191–197. (In Chinese) - 25.
Subarnas, A., Oshima, Y., Hikino, H. Isoflavans and a pterocarpan from Astragalus mongholicus. Phytochemistry; 1991. 30: 2777–2780. DOI: 10.1016/0031-9422(91)85143-N - 26.
Huang, K.C. The Pharmacology of Chinese Herbs. CRC Press, Boca Raton, 1999. (In Chinese) - 27.
Mills, S., Bone, K. Principles and Practice of Phytotherapy. Churchill Livingstone, Edinburgh, 2000. - 28.
Auyeung, K.K., Han, Q.B., Ko, J.K. Astragalus membranaceus : A review of its protection against in flammation and gastrointestinal cancers. Am. J. Chin. Med.; 2016. 44: 1–22. DOI: 10.1142/S0192415X16500014 - 29.
Yoshida, Y., Wang, M.Q., Liu, J.N., Shan, B.E., Yamashita, U. Immunomodulating activity of Chinese medicinal herbs and Oldenlandia diffusa in particular. Int. J. Immunopharmacol.; 1997. 19: 359–370. DOI: 10.1016/S0192-0561(97)00076-3 - 30.
Agyemang, K., Han, L., Liu, E., Zhang, Y., Wang, T., Gao, X. Recent advances in Astragalus membranaceus anti-diabetic research: Pharmacological effects of its phytochemical constituents. Evid. Based Complement. Alternat. Med.; 2013: 654643. DOI: 10.1155/2013/654643 - 31.
Ryu, M., Kim, H.E., Chun, M., Kang, S., Shim, B., Yu, Y.B., Jeong, G., Lee, J.S. Astragali Radix elicits anti-inflammation via activation of MKP-1, concomitant with attenuation of p38 and Erk. J. Ethnopharmacol.; 2008. 115: 184–193. DOI: 10.1016/j.jep.2007.09.027 - 32.
Shen, H.H., Wang, K., Li, W., Ying, Y.H., Gao, G.X., Li, X.B., Huang, H.Q. Astragalus membranaceus prevents airway hyperreactivity in mice related to Th2 response inhibition. J. Ethnopharmacol.; 2008. 116: 363–369. DOI: 10.1016/j.jep.2007.12.002 - 33.
Liu, Y.H., Sun, S., Zhang, H.Q., Zhang, Y.T., Xia, B. 2D NMR study on cycloartane triterpenoids from Astragalus membranaceus var. mongholicus . J. China Pharm. Univ.; 2008. 39: 15–19. (In Chinese) - 34.
Toda, S., Shirataki, Y. Inhibitory effects of Astragali Radix , a crude drug in Oriental medicines, on lipid peroxidation and protein oxidative modification by copper. J. Ethnopharmacol.; 1999. 68: 331–333. DOI: 10.1002/ptr.5188 - 35.
Hong, Y. Oriental Materica: A Concise Guide. Oriental Healing Arts Institute, Long Beach, 1986. - 36.
McCulloch, M., See, C., Shu, X.J., Broffman, M., Kramer, A., Fan, W.Y., Gao, J., Lieb, W., Shieh, K., Colford, J.M. Jr. Astragalus-based Chinese herbs and platinum-based chemotherapy for advanced non-small-cell lung cancer: Meta-analysis of randomized trials. J. Clin. Oncol.; 2006. 24: 419–430. DOI: 10.1200/JCO.2005.03.6392 - 37.
Shih, H.C., Chang, K.H., Chen, F.L., Chen, C.M., Chen, S.C., Lin, Y.T., Shibuya, A. Anti-aging effects of the traditional Chinese medicine Bu-zhong-yi-qi-tang in mice. Am. J. Chin. Med.; 2000. 28: 77–86. DOI: 10.1142/S0192415X00000106 - 38.
Toshiaki, K., Nobuhiko, S., Eiichi, T., Shinya, S., Yutaka, S., Hiroshi, O., Hideki, O., Katsutoshi, T. Assessment of effects of traditional herbal medicines on elderly patients with weakness using a self-controlled trial. Geriatr. Gerontol. Int.; 2004. 4: 169–174. DOI: 10.1111/j.1447-0594.2004.00246.x - 39.
Wagner, H.B., Xiao, P.G., Chen, J., Michler, M.G. Radix Astragali (Huangqi): Chinese Drug Monographs and Analysis Germany. Verlag, Wald, 1997. pp. 1–17. - 40.
Bensky, D., Gamble, A. Chinese Herbal Medicine: Materia Medica, Revised Edition. Eastland Press, Seattle, 1993. - 41.
Chang, H., But, P. Pharmacology and Applications of Chinese Materia Medica, Vol. 2. World Scientific, Singapore, 1987. pp. 1041–1046. - 42.
Yu, S.Y., Ouyang, H.T., Yang, J.Y., Huang, X.L., Yang, T., Duan, J.P., Cheng, J.P., Chen, Y.X., Yang, Y.J., Qiong, P. Subchronic toxicity studies of radix astragali extract in rats and dogs. J. Ethnopharmacol.; 2007. 110: 352–355. DOI: 10.1016/j.jep.2006.09.024 - 43.
Hayashi, H., Sudo, H. Economic importance of licorice. Plant Biotechnol.; 2009. 26: 101–104. DOI: 10.5511/plantbiotechnology.26.101 - 44.
Li, X.Y. A study of the system and new taxa of Genus Glycyrrhiza L. Bull Bot. Research.; 1993. 13: 4–43. (In Chinese) - 45.
Guo, Z., Wu, Y., Wang, R., Wang, W., Liu, Y., Zhang, X.Q., Gao, S., Zhang, Y., Wei, S. Distribution patterns of the contents of five active components in taproot and stolon of Glycyrrhiza uralensis . Biol. Pharm. Bull.; 2014. 37: 1253–1258. DOI: 10.1248/bpb.b14-00173 - 46.
Katakai, M., Akamaru, T., Tani, T. An analysis of the frequency of formulations and crude drugs described in (Shan-Han-Lun). Yakushigaku Zasshi; 2002. 37: 28–35. - 47.
Isbrucker, R.A., Burdock, G.A. Risk and safety assessment on the consumption of Licorice root (Glycyrrhiza sp.), its extract and powder as a food ingredient, with emphasis on the pharmacology and toxicology of glycyrrhizin. Regul. Toxicol. Pharmacol.; 2006. 46: 167–192. DOI: 10.1016/j.yrtph.2006.06.002 - 48.
Asl, M.N., Hosseinzadeh, H. Review of pharmacological effects of Glycyrrhiza sp. and its bioactive compounds. Phytother. Res.; 2008. 22: 709–724. DOI: 10.1002/ptr.2362 - 49.
Wan, J.B., Bai, X., Cai, X.J., Rao, Y., Wang, Y.S., Wang, Y.T. Chemical differentiation of da-cheng-qi-tang, a chinese medicine formula, prepared by traditional and modern decoction methods using uplc/q-tofms-based metabolomics approach. J. Pharm. Biomed. Anal.; 2013. 83: 34–42. DOI: 10.1016/j.jpba.2013.04.019 - 50.
Hinoshita, F., Ogura, Y., Suzuki, Y., Hara, S., Yamada, A., Tanaka, N., Yamashita, A., Marumo, F. Effect of orally administered shao-yao-gan-cao-tang (shakuyaku-kanzo-to) on muscle cramps in maintenance hemodialysis patients: A preliminary study . Am. J. Chin. Med.; 2003. 31: 445–453. DOI: 10.1142/S0192415X03001144 - 51.
Wu, T.H., Chen, L.C., Yang, L.L. Hypouricemic effect and regulatory effects on autonomic function of Shao-Yao Gan-Cao Tang, a Chinese herbal prescription, in asymptomatic hyperuricemic vegetarians. Rheumatol. Int.; 2007. 28: 27–31. DOI: 10.1007/s00296-007-0385-7 - 52.
Satoh, H., Tsuro, K. Pharmacological modulation by Shakuyakukanzoto (Shao-Yao-Gan-Cao-Tang) and the ingredients in rat intestinal smooth muscle. Chin. Med.; 2011. 2: 62–70. DOI: 10.4236/cm.2011.22012 - 53.
Hidaka, T., Shima, T., Nagira, K., Ieki, M., Nakamura, T., Aono, Y., Kuraishi, Y., Arai, T., Saito, S. Herbal medicine Shakuyaku-kanzo-to reduces paclitaxel-induced painful peripheral neuropathy in mice. Eur. J. Pain; 2009. 13: 22–27. DOI: 10.1016/j.ejpain.2008.03.003 - 54.
Komiyama, K., Kawakubo, Y., Fukushima, T., Sugimoto, K., Takeshima, H., Ko, Y., Sato, T., Okamoto, M., Umezawa, I., Nishiyama, Y. Acute and subacute toxicity test on the extract from Glycyrrhiza. Oyo Yakuri; 1977. 14: 535–548. - 55.
Rossi, T., Fano, R.A., Castelli, M., Malagoli, M., Ruberto, A.I., Baggio, G., Zennaro, R., Migaldi, M., Barbolini, G. Correlation between high intake of glycyrrhizin and myolysis of the papillary muscles: an experimental in vivo study. Pharmacol. Toxicol.; 1999. 85: 221–229. DOI: 10.1111/j.1600-0773.1999.tb02012.x - 56.
Sheu, C.W., Cain, K.T., Rushbrook, C.J., Jorgenson, T.A., Generoso, W.M. Tests for mutagenic effects of ammoniated glycyrrhizin, butylated hydroxytoluene, and gum Arabic in rodent germ cells. Environ. Mutagen.; 1986. 8: 357–367. DOI: 10.1002/em.2860080305